São Paulo, May 13th, 2019 – Alliar – Centro de Imagem Diagnósticos S.A. hereby announces its 1Q19 results.
Highlights:
- Net income (Shareholders) grew by 39.2% in the quarter, reaching R$9.9 million. Net income (Proforma) of R$11.9 million, up by 67.6%
- EBITDA margin expanded +504 bps, to reach 27.7% in the quarter, with adjusted EBITDA of R$72.4 million, up by 21.9%. Adjusted 1Q19 EBITDA (Proforma) of R$60.8 million, up +2.3% vs. 1Q18
- Same-store-sales (SSS) of +3.0%, offset mainly by the sale of Hospital São Rafael’s operations, led to a stable net revenue1 (-0.3%) of R$261.6 million in the quarter
- Operating cash generation of R$40.8 million (+24.4%) and cash conversion of 56.4%. The positive free cash flow of R$24.5 million (+91.0%) demonstrates Alliar’s new momentum
- ROIC without goodwill reached 12.8%, up by 69 bps due to the investment maturation strategy
- Net promoter score (NPS) reached 63.0% at the end of 1Q19, increasing by 247 bps vs. 1Q18, reflecting the ongoing improvement processes and the real-time management of patient flow in our units
(1) Excludes “construction revenue”, accounting entry referring to the investment made at RBD (PPP Bahia)
Click here to access the Earnings Release.
| Conference Call in Portuguese |
| May 14, 2019 12:30 p.m. (Local time) 11:30 a.m. (NY time) Phone: +55 (11) 2188-0155 Code: Alliar Webcast: click here |
IR Contact
Frederico de Aguiar Oldani
CFO / IRO
Email: ri@alliar.com